London, July 18 (AFP/APP):Haleon, the consumer healthcare unit spun off by British drugs giant GlaxoSmithKline, was worth around £31 billion ($36 billion) when it began trading in London on Monday. The new company — which owns brands including Sensodyne toothpaste, pain relief drug Panadol and […]